MENU

CRNX Crinetics Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CRNX is expected to report earnings to fall 8.20% to -88 cents per share on March 18

Crinetics Pharmaceuticals CRNX Stock Earnings Reports
Q4'24
Est.
$-0.88
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.08
Q1'24
Missed
by $0.13
Q4'23
Missed
by $0.04
The last earnings report on November 12 showed earnings per share of -95 cents, missing the estimate of -91 cents. With 12.28K shares outstanding, the current market capitalization sits at 5.13B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CRNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with ARWR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.35%
ARWR - CRNX
47%
Loosely correlated
-0.45%
XENE - CRNX
47%
Loosely correlated
-0.07%
ELVN - CRNX
45%
Loosely correlated
+3.48%
PGEN - CRNX
44%
Loosely correlated
+2.46%
RARE - CRNX
43%
Loosely correlated
-0.99%
More